Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity

This publication has 19 references indexed in Scilit:

• Multidrug resistance and its circumvention
  European Journal of Cancer and Clinical Oncology, 1990
• The Clinical Relevance of Multidrug Resistance
  Cancer Investigation, 1990
• CD3-negative natural killer cells express ε TCR as part of a novel molecular complex
  Nature, 1989
• Lymphokine-activated killer (LAK) and monocyte-mediated cytotoxicity on tumor cell lines resistant to antitumor agents
  Cellular Immunology, 1989
• Inhibition of Colony Formation of Drug-resistant Human Tumor Cell Lines by Combinations of Interleukin-2-activated Killer Cells and Antitumor Drugs
  Japanese Journal of Cancer Research, 1989
• Susceptibility of human and murine drug-resistant tumor cells to the lytic activity of rIL2 - activated lymphocytes (LAK)
  Cancer and Metastasis Reviews, 1988
• New Approaches to the Immunotherapy of Cancer Using Interleukin-2
  Annals of Internal Medicine, 1988
• Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleen
  Immunology Today, 1987
• Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies.
  Proceedings of the National Academy of Sciences, 1986
• Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
  Nature, 1985